Genes Influencing Impulse Control and Addiction Risk
Genetic predisposition addiction risk plays a crucial role in poor impulse control linked to cannabis use disorder. Understanding these genetic factors helps clinicians identify patients at higher addiction risk. This knowledge supports personalized…
Radical Revelations: Nitrosative Stress and the Endocannabinoid System
Understanding nitrosative stress endocannabinoid system interactions is crucial for predicting patient responses to cannabis-based therapies. This knowledge aids clinicians in personalizing treatments for neuroinflammatory and oxidative stress disorders.…
Specific Forms of Substance Misuse Increase Stroke Risk – MPR – eMPR.com
Emerging evidence links cannabis use disorder stroke risk to increased incidence of stroke, especially in younger patients. Clinicians should screen for cannabis use disorder stroke risk when assessing stroke causes. Understanding cannabis use disorder…
Rethinking Cannabis and Its Effects on the Aging Brain
Understanding aging brain cannabis effects is crucial for clinicians treating older adults. Cannabis use among seniors is rising despite limited safety data. This article reviews key considerations for cognitive function and neurodegeneration in…
Ethics Committee in the Netherlands Approves Parkinson’s Cannabis Trial
The cannabis-derived therapeutic candidate Parkinson's disease trial has received ethics committee approval in the Netherlands. This milestone advances clinical evidence for cannabinoid treatments in neurodegenerative conditions. Clinicians should…
From relationships to cannabis neuroscience: WWU’s podcast covers it – The Western Front
This article highlights cannabis neuroscience harm reduction as featured in WWU's podcast. It provides clinicians with evidence-based insights to counsel patients on safer cannabis use. Understanding neurobiological effects is key to effective harm…
Artelo Biosciences Advances Peripheral Cannabinoid Agonists for Glaucoma
Peripheral cannabinoid receptor agonists glaucoma research is advancing with promising synthetic compounds like ART12.11. These therapies aim to reduce intraocular pressure, a key factor in glaucoma management. Clinicians should monitor emerging data on…
Lawmakers Send Right to Try Medical Cannabis Act, Ibogaine Trials to Governor
The Right to Try Medical Cannabis Act expands patient access to cannabis outside standard trials. This legislation allows compassionate use for serious conditions. Clinicians must understand this act to guide patients on safety and legal issues.
Cannabis Linked to Major Memory and Health Risks – Clinical Review
Recent evidence highlights cannabis memory impairment as a significant clinical concern, particularly affecting cognitive function. Cannabis use is linked to broader health risks including cannabinoid hyperemesis syndrome. Clinicians should screen for…
The Endocannabinoid System, Immunomodulation, and LPS-Induced Inflammation
Understanding endocannabinoid system immunomodulation is critical for clinicians managing inflammatory conditions. This system regulates immune responses and inflammation triggered by lipopolysaccharide exposure. Insights into this mechanism inform…
